Pakistan journal of pharmaceutical sciences · 2026
miR-193a-5p carried by ferric oxide nanoparticles interferes with the TGF-β1/Smad signaling pathway and promotes pyroptosis in gastric cancer cells.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yu Huijuan, Lu Ye, Chen Ziqin, Du Xiaoshuang
Аннотация
BACKGROUND: The transforming growth factor -β1 (TGF-β1) /Smad signaling pathway plays a critical role in gastric cancer pathogenesis.
OBJECTIVE: This study investigates how microRNA-193a-5p (miR-193a-5p) delivered by iron oxide nanoparticles (Fe3O4 nanoparticles, NPs) influences gastric cancer cell pyroptosis through TGF-β1/Smad signaling.
METHODS: The MiR-193a-5p-Fe3O4 NPs composite material was constructed to treat human gastric cancer cells MKN28. The control group, miR-193a-5p group, Fe3O4 NPs group, MiR-193a-5p-Fe3O4 NPs group and the combined treatment group of pathway inhibitors/activators were set up. Detect the expression of proteins related to cell proliferation, migration, apoptosis and pyroptosis.
RESULTS: miR-193a-5p-Fe3O4 NPs can significantly inhibit the proliferation and migration of gastric cancer cells, induce apoptosis and pyroptosis and down-regulate the activity of the TGF-β1/Smad pathway. The combination of TGF-β pathway inhibitor SB431542 can enhance the above effect, while the activator SIS-011381 can partially reverse this effect.
CONCLUSION: miR-193a-5p-Fe3O4 NPs promote pyroptosis of gastric cancer cells by inhibiting the TGF-β1/Smad signaling pathway. Its combination with SB431542 has a synergistic anti-tumor effect, providing a new idea for the treatment of gastric cancer.
OBJECTIVE: This study investigates how microRNA-193a-5p (miR-193a-5p) delivered by iron oxide nanoparticles (Fe3O4 nanoparticles, NPs) influences gastric cancer cell pyroptosis through TGF-β1/Smad signaling.
METHODS: The MiR-193a-5p-Fe3O4 NPs composite material was constructed to treat human gastric cancer cells MKN28. The control group, miR-193a-5p group, Fe3O4 NPs group, MiR-193a-5p-Fe3O4 NPs group and the combined treatment group of pathway inhibitors/activators were set up. Detect the expression of proteins related to cell proliferation, migration, apoptosis and pyroptosis.
RESULTS: miR-193a-5p-Fe3O4 NPs can significantly inhibit the proliferation and migration of gastric cancer cells, induce apoptosis and pyroptosis and down-regulate the activity of the TGF-β1/Smad pathway. The combination of TGF-β pathway inhibitor SB431542 can enhance the above effect, while the activator SIS-011381 can partially reverse this effect.
CONCLUSION: miR-193a-5p-Fe3O4 NPs promote pyroptosis of gastric cancer cells by inhibiting the TGF-β1/Smad signaling pathway. Its combination with SB431542 has a synergistic anti-tumor effect, providing a new idea for the treatment of gastric cancer.